United States Science Under Siege

AUTHOR: Elie A. Shneour, pp.14 The standing and credibility of the United States scientific community are under unprecedented political and economic challenge. At issue are such matters as animal rights terrorism; limits on reproductive and fetal research; discrediting of scientific evidence in the making of public policy; accountability in the management of research funds; and a parasitic bureaucracy purporting to define, review, and punish scientific misconduct. The contrast with the post-W

Written byElie Shneour
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

AUTHOR: Elie A. Shneour, pp.14

The standing and credibility of the United States scientific community are under unprecedented political and economic challenge. At issue are such matters as animal rights terrorism; limits on reproductive and fetal research; discrediting of scientific evidence in the making of public policy; accountability in the management of research funds; and a parasitic bureaucracy purporting to define, review, and punish scientific misconduct.

The contrast with the post-World War II period could not be starker: Then, science was glorified with the invention of radar, the prospect of benevolent nuclear power, and the promise of more to come. Science was poised to enter the golden age of molecular biology and peer into the nature of our universe. Rep. John E. Fogarty (D-R.I.), working closely with National Institutes of Health director James A. Shannon (1955-1968), dedicated much of his legislative life to expanding the scope of biomedical research, while ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies